Medical Design Technology

The Essential Resource for the Medical Design Engineering Community

Subscribe to MDT Magazine All

Frequent Heartburn May Predict Cancers of the Throat and Vocal Cord

May 23, 2013 10:00 am | by AACR | News | Comments

Frequent heartburn was positively associated with cancers of the throat and vocal cord among nonsmokers and nondrinkers, and the use of antacids, but not prescription medications, had a protective effect, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

TOPICS:

Cardiovascular Systems Presents New Late-Breaking Coronary Results at EuroPCR Conference

May 23, 2013 10:00 am | by The Associated Press | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--May 23, 2013--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), presented 30-day results from its ORBIT II study of coronary artery disease in a late-breaking presentation at the 2013 European Association of Percutaneous Cardiovascular Interventions (EuroPCR)...

TOPICS:

Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results

May 23, 2013 9:29 am | by PR Newswire | News | Comments

TARRYTOWN, N.Y., May 23, 2013 /PRNewswire/ -- Direct to implant, or "one step," breast reconstruction following mastectomy is an appropriate option for many women with BRCA (BReast CAncer) gene mutations seeking to surgically reduce their breast cancer risk, or with breast...

TOPICS:
Advertisement

Study Finds 35 to 42 Percent Daily Cost Savings for Hospitals Using Flexi-Seal® Fecal Management System

May 23, 2013 9:00 am | by PR Newswire | News | Comments

SKILLMAN, N.J., May 23, 2013 /PRNewswire/ -- A new study of the costs of managing fecal incontinence in intensive care units (ICUs) at two Canadian hospitals has found a 35 to 42 percent decrease in daily material costs with the Flexi-Seal® Fecal Management System (FMS) compared...

TOPICS:

Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO Annual Meeting

May 23, 2013 8:30 am | by The Associated Press | News | Comments

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, from May 31 through June 4, 2013. Atossa's exhibit will be located in booth 2019...

TOPICS:

Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference

May 23, 2013 8:30 am | by PR Newswire | News | Comments

TEL AVIV, Israel, May 23, 2013 /PRNewswire/ -- Israel Brain Technologies (IBT) has announced the launch of BrainTech Israel 2013, Israel's 1st International Brain Technology Conference, which will take place on October 14th-15th in Tel Aviv, recently ranked as the 2nd most innovative...

TOPICS:

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity Renal Denervation System for Treatment-Resistant Hypertension

May 23, 2013 6:06 am | by The Associated Press | News | Comments

Medtronic, Inc., today announced it has finished randomizing Symplicity HTN-3, the company's pivotal U.S. clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure to reduce activity of the renal (kidney) nerves, which are part of the sympathetic nervous system and help regulate blood pressure.

TOPICS:

InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group

May 23, 2013 6:00 am | by PR Newswire | News | Comments

InspireMD, Inc., the leader in embolic protection stents, today announced new 6-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard Embolic Protection Stent (EPS) outperformed bare metal and drug eluting stents in all-cause mortality in ST segment elevation myocardial infarction (STEMI) patients.   

TOPICS:
Advertisement

Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013

May 23, 2013 4:30 am | by PR Newswire | News | Comments

SAN DIEGO and PARIS, May 23, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary...

TOPICS:

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013 4:15 am | by The Associated Press | News | Comments

ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--May 23, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the company’s EnligHTN ™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after...

TOPICS:

Consumer Information on: Selenia Dimensions 3D System - P080003S001

May 23, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

The Selenia Dimensions 3D System is comprised of hardware and software upgrades to the Selenia Dimensions 2D full-field digital mammography system, which is FDA approved for conventional mammography. The hardware upgrades produces multiple, low-dose x-ray images of the breast; the software upgrade uses the low-dose x-ray images to create cross-sectional (tomosynthesis) views of the breast.

TOPICS:

Meeting Announcement: June 26, 2013 General and Plastic Surgery Devices Panel of the Medical Devices Meeting Announcement

May 23, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

On June 26, 2013, the committee will discuss and make recommendations regarding the possible reclassification of blood lancet devices.  The committee will discuss whether new scientific data are sufficient to support the reasonable assurance of safety and effectiveness to develop special controls that support regulation of blood lancets from class I to class II and class III. 

TOPICS:

New Michigan-Based Medical Product Manufacturing Effort Provides Solutions for Innovators

May 22, 2013 5:27 pm | by The Associated Press | News | Comments

The University of Michigan Pediatric Medical Device Consortium (M-PED) is launching a new medical product manufacturing video on Vimeo. This 28-minute video: "Innovative Pediatric Manufacturing: Strategies & Solutions - A Guide To Bringing Your Device To Market" features critical...

Replacing the Cadaver for Surgical Students

May 22, 2013 4:06 pm | by Kasey Panetta, Managing Editor, ECN | Articles | Comments

Surgical simulators are an ideal solution for training surgeons with minimal risk to patient health and safety. This is particularly important when surgeons train for procedures utilizing arthroscopy because it requires the surgeon to perform the surgery while looking at a camera screen instead of the patient. This necessitates extensive training to ensure the doctor is an expert in the method.

TOPICS:

3D PRINTING WITH FDM: How it Works

May 22, 2013 3:13 pm | by Stratasys | White Papers

A 3D printer is a machine that creates objects from plastic or other materials using an additive manufacturing process. Additive manufacturing produces objects in a succession of layers from the bottom, up. This is the opposite of traditional subtractive manufacturing processes, which produce objects by cutting material away from a block to create the shape desired.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading